{"paper_id":"0d96974c-ed30-4541-888e-b47ab3840b97","body_text":"Endometriosis is defined as the presence of endometrial stroma and glands outside the uterine cavity. It is present in 3% to 15% of fertile women,\n 1 \nand it affects women's quality of life, causing chronic pelvic pain, dyspareunia, infertility, as well as certain deleterious sexual effects in 67% of the cases.\n 2 \nIn contrast, deep infiltrating endometriosis (DIE) consists of the penetration of the endometrial tissue more than 5 mm below the peritoneal surface.\n 3\nThe literature reports that endometriotic disease is the main cause of dyspareunia, and it affects 60% to 70% of women undergoing surgery. The common presence of DIE on cardinal and uterosacral ligaments, on the pouch of Douglas and on the posterior vaginal fornix represents a nine-old increase in the risk of developing dyspareunia.\n 2 \n 4\nDyspareunia does not cause only pain: it is also associated with psychological and psychosocial injury. Feelings of fear during intercourse, as well as guilt, are predominant among DIE patients, and they directly and indirectly affect domains of sexual function such as desire, frequency, pleasure and orgasm.\n 5\nThe treatment for endometriosis is mainly focused on pain control and quality of life improvement, including, sexual life. Hormonal therapies are effective for pain control during disease progression, but they can also lead to gonadal suppression and reduced sexual response.\n 6 \nHowever, surgical procedures and radical resection of all visible endometriosis nodules may improve quality of life in up to 85% to 95% of severe to moderate cases.\n 7\nAccording to international guidelines, endometriosis is a chronic disease that requires a life-long management plan to control pain symptoms and to avoid multiple surgical procedures.\n 8 \nHormonal therapies to achieve a hypoestrogenic status are effective to control pain and disease progression, but they are also associated with gonadal suppression and reduced sexual response.\n 6 \nThe aim of the surgical treatment is the excision of all endometriosis lesions to improve pain and infertility. However, in cases of extensive DIE, surgery is associated with peri- and postoperative complications, as well as a decrease in sexual function.\n 9\nThus, the present systematic review aims to assess how surgery affects sexual function and dyspareunia in patients undergoing surgical treatment to treat DIE.\n\nThe present systematic review was conducted in accordance with the Meta-Analysis of Observational Studies in Epidemiology (MOOSE) guidelines. The study protocol was registered at the at the International Prospective Register of Systematic Reviews (PROSPERO; registration CRD 42021289742) and followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement.\n 10\nWe performed a search in the following databases: PubMed, EMBASE, Cochrane Library, LILACS, and Web of Science from inception to December 2022. The main keywords used were\n deep endometriosis \n,\n sexual function \n,\n resection \n, and\n shaving \n. The full search strategy used can be found in\n Chart 1 \n.\nTwo independent reviewers (GC and DF) were invited to analyze all articles found. Initially, an analysis of the titles and abstracts was performed to screen for potential eligible studies. Later, the reviewers evaluated the fully screened articles to select eligible studies. Disagreements were resolved by joint review and consensus among reviewers.\nTo comply with the objectives of the present systematic review, the eligibility criteria were as follows: comparative studies on female sexual function before and after surgery for deep endometriosis; studies with women previously diagnosed with deep endometriosis by physical examination or complementary imaging exams submitted to surgery; and studies with the application of standardized questionnaires to assess sexual function and dyspareunia. No clinical treatment associated with surgery was established, neither a limited time of follow-up after surgery, nor were there language restrictions during the initial search. The exclusion criteria were: conference abstracts, case reports, case series, reviews, and duplicate studies. In the full-text analysis, articles published in languages other than English, Portuguese, Italian, Spanish, and French were also excluded.\nThe two reviewers (GC and DF) inserted the data from all the included studies in a Microsoft Excel 2010 (Microsoft Corp., Redmond, WA, United States) spreadsheet. We extracted general variables form the studies, such as authorship, year of publication, country, type of study, follow-up, surgery performed, age of the patients, and the number of patients included. We also recorded the name of the questionnaire used for the evaluation of sexual function and dyspareunia. The heterogeneity among the studies and questionnaires found in the literature did not enable the performance of a meta-analysis.\nThe outcome of interest was the assessment of sexual function before and after surgery using a validated questionnaire. The presence of dyspareunia before and after the surgery was also evaluated.\nTo evaluate the risk of bias in non-randomized studies (such as case-control and cohort studies), we used the Newcastle-Ottawa Scale (NOS), while the risk of bias in randomized controlled trials (RCT) was evaluated using the Cochrane Collaboration's tool (RoB-1).\n 11 \n 12\nThe NOS is based on a star scoring system in which the observational study is assessed in terms of three broad parameters: selection of the study groups; comparability of the groups; and ascertainment of either the exposure or the outcome of interest for case-control or cohort studies respectively.\n 11 \nOn the other hand, the RoB-1 covers six domains of the possible biases of RCTs: selection bias, performance bias, detection bias, attrition bias, reporting bias, and other biases. Each domain is classified as low, high, or unclear risk of bias.\n 12\n\nWe found 1,100 studies; after removing the duplicates, 831 studies were screened for titles and abstracts by 2 reviewers who selected 108 studies for full-text analyses. Finally, a total of 20 studies fulfilled the eligibility criteria and were included in the present systematic review. A flowchart of the search and selection of studies is summarized in\n Fig. 1 \n.\nFlowchart o the search and selection of studies.\nObservational studies and one RCT were included in the review. Half of the cohort studies (50%) had a score ≥ 7 stars on the NOS scale, while 38% had 6 stars, and 2, ≤ 5 stars. The RCT had a score of 6 stars on the NOS scale; it was on a comparison of laparoscopic surgeries with and without uterosacral ligament resection, and it presented an unclear risk of bias for random sequence generation and allocation sequence concealment, and a high risk for blinding of the outcome assessment. In total, the studies included evaluated 2,145 patients with follow-ups ranging from 3 to 69 months. The characteristics of the included studies are presented in\n Chart 2 \n.\nAbbreviations: B-PFSF, Brief Profile of Female Sexual Function; CG, control group; CO\n 2 \n, carbon dioxide; DIE, deep infiltrating endometriosis; DSFI, Derogatis Sexual Functioning Inventory; FSDS, Female Sexual Distress Scale, revised; FSFI, Female Sexual Function Index; GSSI, Global Sexual Satisfaction Index; HG, healthy group; KFSP, Kurzfragebogen Sexualität und Partner-schaft; MFSQ, McCoy Female Sexuality Questionnaire modified by Wiklund et al; NRS, Numeric Rating Scale; SAQ, Sexual Activity Questionnaire; SSFS, Short Sexual Functioning Scale; SHOW-Q, Sexual Health Outcomes in Women Questionnaire; SQoL-F, Sexual Quality of Life − Female Questionnaire; SQV, Sexual Function-Vaginal Changes Questionnaire; SSRS, Sabbatsberg Sexual Rating Scale; VAS, Visual Analogue Scale; WB, with bowel resection; WOB, without bowel resection.\nA comparison of the pre- and postoperative outcomes regarding sexual function and dyspareunia is shown in\n Chart 3 \n.\nAbbreviations: B-PFSF, Brief Profile of Female Sexual Function; CG, control group; DIE, deep infiltrating endometriosis; DSFI, Derogatis Sexual Functioning Inventory; FSDS, Female Sexual Distress Scale, revised; FSFI, Female Sexual Function Index; GSSI, Global Sexual Satisfaction Index; KFSP, Kurzfragebogen Sexualität und Partner-schaft; MFSQ, McCoy Female Sexuality Questionnaire modified by Wiklund et al; NP, no parametrial group; P, parametrial group; SAQ, Sexual Activity Questionnaire; SFSS, Short Sexual Functioning Scale; SHOW-Q, Sexual Health Outcomes in Women Questionnaire; SQoL-F, Sexual Quality of Life − Female Questionnaire; SQV, Sexual Function-Vaginal Changes Questionnaire; SSRS, Sabbatsberg Sexual Rating Scale; USL, uterosacral ligament; WB, with bowel resection; WOB, without bowel resection.\nThe predominant surgical technique used to treat DIE patients was laparoscopic surgery. A total of 14 articles used only the laparoscopy technique for DIE excision, while 3 studies associated it with the CO\n 2 \nlaser technique.\n 13 \n 14 \n 15 \nTwo studies performed vaginal surgery associated with the laparoscopic procedure, when necessary,\n 16 \n 17 \nand one combined laparoscopy with transurethral surgery.\n 18\nIn one study,\n 18 \ntransurethral and laparoscopic surgeries to resect bladder endometriosis presented a significancy improvement in sexual function in all 6 domains of the Female Sexual Function Index (FSFI), with a postoperative score of 28.2 +/− 1.7. Setälä et al.\n 16 \nand Fritzer et al.\n 17 \nperformed vaginal surgery associated with videolaparoscopy procedures to resect vaginal endometriosis lesions, resulting in a significant increase on sexual comfort and pleasure according to the modified McCoy Female Sexuality Questionnaire (MFSQ).\n 16 \nHowever, the study by Fritzer et al.\n 17 \ndid not show significant results in the final FSFI score in any of the three population groups compared (DIE, vaginal resection, and peritoneal endometriosis).\n 17 \nSexual function after the CO\n 2 \nlaser technique was evaluated by two different questionnaires.\n 13 \n 14 \n 15 \nThe Sexual Activity Questionnaire (SAQ) showed significant postoperative improvement on the following pillars of sexual function: pleasure, habit\n 13 \n 15 \nand discomfort.\n 15 \nThe Short Sexual Function Scale (SSFS) only presented significant improvement in the pillar of orgasm after surgery.\n 14\nOther articles also evaluated sexual function and DIE of the bowel. A comparative study\n 19 \nanalyzed sexual function for the following sixty-nine months after DIE surgery with and without bowel resection. Postoperatively, the patients without bowel resection improved significantly in all categories on the Kurzfragebogen Sexualität und Partner-schaft (KFSP) questionnaire. Not only no significant postoperative improvement was observed in the patients in the bowel endometriosis group, but this group had significantly poorer scores in comparison with the control group.\n 19 \nRiiskjaer et al.\n 20 \nperformed laparoscopy for DIE of the bowel and observed positive results on the Sexual Function-Vaginal Changes Questionnaire (SQV) after one year of follow-up: there was a significant increase in vaginal changes, general sexual satisfaction, desire for sexual intercourse, and frequency of sexual intercourse. Laparoscopic resection for bowel endometriosis also resulted in an increase in sexual satisfaction on the overall MFSQ score one year after surgery in one study.\n 21 \nSexual problems and satisfaction with partner scores did not change significantly in another study.\n 22\nThe surgical data related to the female sexual function response in the studies analyzed were collected and presented in\n Chart 4 \n.\nAbbreviations: DIE, deep infiltrating endometriosis; rAFS, revised American Fertility Society classification; USL, uterosacral ligament; WO, with bowel resection; WOB, without bowel resection.\nThe extension of the endometriosis was ascertained intraoperatively using the revised American Fertility Society (rAFS)\n 22 \nand the Enzian scale\n 23 \nin 13 studies.\n 13 \n 14 \n 15 \n 16 \n 17 \n 19 \n 24 \n 25 \n 26 \n 27 \n 28 \n 29 \n 30 \nIn the evaluated articles, 45.32% of the patients were classified as rAFS class IV (severe), followed by 27.67% as class III (moderate),13.65% as class II (mild), and 13.40% as class I (minimal). The most common pelvic sites of DIE involvement were: the uterosacral ligaments (51.24%), the bowel (31.56%), the vagina (14.45%), the rectovaginal septum (8.89%) and the retrocervical nodule (6.46%).\n 14 \n 19 \n 20 \n 21 \n 25 \n 26 \n 28 \n 29 \n 30 \n 31\nThree comparative studies\n 25 \n 26 \n 32 \nevaluated sexual function after resection of the uterosacral ligament. In two of them,\n 25 \n 26 \nthe authors used the Derogatis Sexual Functioning Inventory (DSFI) and Global Sexual Satisfaction Index (GSSI) to analyze sexual function 6 and 12 months postoperatively, and found a significant increase in sexual function up to 6 months. Frequency and orgasm on the DSFI were not significant at the 12-month follow-up.\n 25 \n 26 \nSimilar results were presented by Vercellini et al.\n 32 \nafter 18 months of follow-up, with no significant improvement in sexual function on the Sabbatsberg Sexual Rating Scale (SSRS).\nAn improvement in sexual function was also observed on FSFI scores after resection of bladder endometriosis,\n 18 \nas well as a significant improvement in sexual satisfaction and intercourse pain on the MFSQ after twelve months of surgery in a group of women with DIE submitted to vaginal nodule resection.\n 16\nThe nerve-sparing surgical technique for DIE excision was described as necessary in six articles,\n 13 \n 14 \n 15 \n 28 \n 29 \n 33 \nin which different results were found: two studies\n 15 \n 29 \nshowed a significant improvement on the SAQ and the FSFI's global sexual function score; two other studies\n 13 \n 33 \nreported partial improvement in some domains on the FSFI and on the Sexual Health Outcomes in Women Questionnaire (SHOW-Q); and the two remaining studies\n 14 \n 28 \nreported no difference in sexual response after the nerve-sparing surgery. Only one article\n 28 \naimed to evaluate the functional results after nerve-sparing posterolateral parametrial surgery, and the authors observed an increased risk of postoperative dyspareunia and sexual dysfunction. The FSFI sexual function score improved in the group without parametrial surgery, but not significantly.\n 28\nThe diagnosis of endometriosis was confirmed by histological examination of specimens removed during surgery in 15 studies.\n 13 \n 14 \n 15 \n 17 \n 18 \n 20 \n 21 \n 24 \n 25 \n 26 \n 28 \n 30 \n 31 \n 33 \n 34 \nComplementary surgical procedures for the treatment of endometriosis, including ureterolysis, adhesiolysis, salpingectomy and appendicectomy, were performed in ten articles.\n 13 \n 14 \n 15 \n 16 \n 21 \n 24 \n 27 \n 28 \n 29 \n 33 \nIntraoperative or postoperative complications were reported in nine studies,\n 13 \n 15 \n 16 \n 21 \n 24 \n 27 \n 28 \n 29 \n 33 \nand the most common findings were transfusions caused by bleeding, transitory urinary retention, and bowel iatrogenic injury. Despite the complication rates reported, only one study\n 28 \ndid not show a significant increase in sexual function after surgery.\nThe clinical treatment was an important point observed on this review. Some articles did not establish inclusion or exclusion criteria regarding the use of hormonal drug treatment associated with the procedure, but six studies\n 13 \n 17 \n 25 \n 26 \n 32 \n 33 \n 34 \ndefined these criteria as In five studies,\n 17 \n 25 \n 26 \n 32 \n 34 \nhormonal treatment with gonadotropin-releasing hormone (GnRH) analogues and combined or isolated contraceptives were discontinued six months before the procedure, and two studies\n 25 \n 32 \ndid not reintroduce any type of hormonal treatment postoperatively. All studies presented an increase on sexual function, except, the one by Vercellini et al.,\n 32 \nwhich did not show positive results on the SSRS after surgery.\nOne study\n 13 \nincluded a GnRH analogue preoperatively, and other studies included combined contraceptives preoperatively\n 31 \n 33 \nand postoperatively.\n 33 \nDespite the differences regarding the hormonal treatment, the sexual function score on the SAQ and SHOW-Q improved postoperatively in two of these studies.\n 31 \n 33\nDyspareunia, also called by some authors deep dyspareunia (DD) or pain during sexual intercourse, was assessed in 12 articles,\n 13 \n 14 \n 15 \n 16 \n 17 \n 20 \n 24 \n 26 \n 27 \n 28 \n 32 \n 33 \nmainly through the Visual Analogue Scale (VAS) and the Numeric Rating Scale (NRS). Only Riiskjaer et al.\n 20 \nobserved dyspareunia as an isolated finding, and evaluated it with its specific scale.\nThree studies\n 17 \n 27 \n 34 \nidentified a significant decrease in dyspareunia according to the NRS scale in all groups in the pre and postoperative comparison. The VAS was applied by the other articles to evaluate dyspareunia after surgery, and all articles reported a significant improvement in pain during intercourse after surgery, including progressive improvement in dyspareunia over time. Only one study\n 14 \ndid not report a decrease in dyspareunia after 18 months of follow-up.\n\nDue to its diverse origin, endometriosis presents great heterogeneity in terms of anatomical presentation and clinical manifestations, especially if associated with the complexity of multifactorial sexual aspects.\nQualitative and quantitative studies have shown that symptomatic endometriosis negatively affects female sexual function, causing discomfort, and they have analyzed these results through global scores. The isolated analysis of the domains of sexual function is unclear, and it is often not the main objective of studies, which limits a comprehensive assessment of sexual functioning. Therefore, the evidence in the literature lacks quality in terms of research design, diagnostic instruments, power of the study, or adjustment for confounding factors.\nThe present review helped expand the knowledge on the types of surgery performed to treat deep endometriosis, and we systematically analyzed the techniques used according to the location and staging of the disease, histopathological confirmation, nerve preservation, and the types of procedures performed for lesion resection.\nThe improvement in sexual function and dyspareunia after the surgical treatment in DIE patients was duly expressed by the authors of the studies reviewed. The laparoscopic surgery technique showed precision to treat DIE, in addition to the surgeons' experience. This statement is corroborated when there are positive results after surgeries, in addition to the correlation with other types of drug treatments.\nAll groups of patients classified according to the rAFS showed improvement in the quality of sexual life, especially those in classes IV and III; however it was not possible to identify the statistical relevance of the improvement in sexual function correlated with each group separately.\n 35 \n 36\nAutonomic, sympathetic, and parasympathetic nerves control the vessels in the genital region, and they are responsible for sexual satisfaction and lubrication. The nerve-sparing surgery for DIE is recommended to reduce patient morbidity.\n 37 \nHowever, 73.68% of the studies in this review did not perform the nerve-sparing surgery, neither did they find a direct correlation with female sexual function, as the literature.\n 29 \n 38\nThe presence of DIE in the vagina and uterosacral ligaments is associated with impaired sexual function and dyspareunia.\n 39 \nThe present review showed an improvement in female sexual function and postoperative dyspareunia despite the location of the endometriosis lesions, disease severity, and surgical treatment performed. We believe that the excision of inflammatory and angiogenic factors caused by DIE during surgery is the main factor for pain relief during sexual intercourse. Getting rid of feelings of fear and anguish caused by pain are also related to the improvement on other factors of sexual function.\nIn addition, the analysis related to deep dyspareunia still needs to be better developed, since the use of the NRS or probing alone is very simplistic compared with the psychological tests to distinguish deep dyspareunia from vulvodynia or vaginismus, which can also be triggered by chronic pelvic pain.\nThe lack of standardization among the questionnaires used to assess sexual function was a limiting factor in the present review, and it is due to the absence of an instrument capable of encompassing the complexity of DIE and its association with female sexual function. However, we were able to oppose some limiting factors found in the literature, such as follow-up time and questionnaire results.\n 40 \nWe evaluated some studies with a follow-up longer than one year and with sexual function results demonstrated through the analysis of the domains involved in sexual response, such as arousal, satisfaction, pleasure and others.\n\nHighly-complex surgical approaches for the treatment of endometriosis have always been associated with the risk of complications arising from the excision of deep endometriotic lesions located mainly in the posterior vaginal fornix, rectal muscular layer, and inferior hypogastric plexus, which could worsen the patient's sexual quality of life and pain symptoms. Despite this, the present review demonstrated that radical surgeries for the treatment of DIE improved dyspareunia and sexual function, and they should be provided to women as a treatment alternative. Healthcare professionals should address the topic of sexual health in consultations with women with endometriosis because improvements following surgery can be expected. The present study not only demonstrates a significant reduction in dyspareunia symptoms, but it also shows that the resection of both minimal and extensive endometriotic disease causes major positive changes in sexual function.","source_license":"CC0","license_restricted":false}